Evolution of immune escape mechanisms in the progression from preinvasive to invasive human lung adenocarcinoma Read more about Evolution of immune escape mechanisms in the progression from preinvasive to invasive human lung adenocarcinoma
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial Read more about BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy Read more about Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy